Gain Therapeutics, a clinical-stage biotech company, announced it will attend the 2026 Maxim Growth Summit in New York City from October 12-14. The company will meet with institutional investors and Maxim research analysts to discuss its development of next-generation allosteric small-molecule therapies, including its lead drug candidate rexaceract for Parkinson's disease. This participation highlights Gain's efforts to advance its pipeline and attract investment for ongoing clinical trials and research in neurodegenerative and rare diseases. The summit features industry leaders and offers Gain a platform to showcase its innovative drug discovery technology and clinical progress.
Gain Therapeutics' participation in the 2026 Maxim Growth Summit coincides with a mixed day for health-sector stocks on Pluang. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 08, 2026 18:11 WIB: out of 100 priced US health-sector stocks, 25 rose and 68 fell. Notable movers include AMLX at USD 27.89 with a 1.68% increase and a typical hold time of 15 days, CTXR at USD 0.50 down 1.57% with 90% buy order activity, and CRSP at USD 51.54 down 1.55% with 76% buy order activity and a typical hold time of 77 days.
Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Beam Global has signed a definitive agreement to acquire ScoutDI, a company specializing in drone technology and AI-powered inspection software. The acquisition will enable Beam to manufacture ScoutDI's drone systems in the US and Europe, targeting i...
Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The clai...
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
